🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

148,36 USD

Máx. histórico

156,45

69 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,17%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-0,78%

Cierre anterior

149,52

Rango de hoy

147,12 – 150,25

Volumen hoy

9.050.917

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
149,86 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
159,91 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 17 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,29%
Fecha de pago Importe por participación
04/03/1974 0,0093 USD
03/12/1973 0,0093 USD
31/08/1973 0,0078 USD
05/06/1973 0,0078 USD
05/03/1973 0,0078 USD
05/12/1972 0,0078 USD
09/06/1972 0,0073 USD
02/03/1972 0,0073 USD
06/12/1971 0,0073 USD
03/09/1971 0,0073 USD
07/06/1971 0,0073 USD
02/03/1971 0,0073 USD
01/12/1970 0,0073 USD
02/09/1970 0,0066 USD
02/06/1970 0,0066 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/11/2025 93,23 94,75 92,68 92,86 -0,06% 2,22% 14.345.800
14/11/2025 92,20 95,08 91,49 92,92 -0,01% 3,89% 19.632.000
13/11/2025 91,31 94,26 90,90 92,93 +1,62% 3,68% 16.086.100
12/11/2025 91,41 92,91 91,16 91,45 +0,55% 1,91% 13.218.900
11/11/2025 87,35 91,07 87,26 90,95 +4,84% 4,36% 15.436.000
10/11/2025 86,69 87,37 85,80 86,75 +0,54% 1,81% 8.319.600
07/11/2025 85,95 86,59 85,24 86,28 +0,58% 1,57% 9.214.300
06/11/2025 84,48 86,17 84,35 85,78 +1,65% 2,15% 10.601.400
05/11/2025 84,03 85,38 82,91 84,39 +0,63% 2,94% 9.440.200
04/11/2025 82,70 84,96 82,01 83,86 +1,66% 3,57% 12.846.100
03/11/2025 85,77 86,10 82,34 82,49 -4,06% 4,38% 13.875.800
31/10/2025 85,42 86,46 84,56 85,98 -0,35% 2,22% 12.385.000
30/10/2025 84,62 87,30 83,30 86,28 -0,35% 4,73% 16.678.800
29/10/2025 86,95 87,84 86,07 86,58 -0,52% 2,04% 10.921.900
28/10/2025 88,11 88,11 86,93 87,03 -1,10% 1,34% 8.345.900
27/10/2025 87,51 88,30 87,03 88,00 +0,58% 1,45% 7.226.600
24/10/2025 87,33 88,06 87,11 87,49 +0,36% 1,09% 7.902.100
23/10/2025 87,56 88,11 86,91 87,18 -0,49% 1,37% 7.687.500
22/10/2025 87,68 88,79 87,01 87,61 -0,01% 2,03% 10.926.300
21/10/2025 86,96 87,67 86,23 87,62 +1,51% 1,66% 9.852.400
20/10/2025 85,25 87,00 85,03 86,32 +1,80% 2,31% 8.611.800
17/10/2025 83,28 84,89 83,16 84,79 +1,04% 2,08% 10.758.900
16/10/2025 84,41 85,50 83,60 83,92 -0,23% 2,25% 11.709.100
15/10/2025 84,19 84,69 83,61 84,11 -0,70% 1,28% 9.168.700
14/10/2025 85,38 85,68 84,15 84,70 -1,17% 1,79% 9.675.000
13/10/2025 85,66 86,46 85,24 85,70 -0,34% 1,42% 6.553.900
10/10/2025 87,94 88,24 85,92 85,99 -1,73% 2,64% 11.230.700
09/10/2025 86,96 87,80 86,64 87,50 +1,27% 1,33% 10.938.200
08/10/2025 87,93 87,93 86,20 86,40 -1,38% 1,97% 9.696.200
07/10/2025 88,67 88,94 87,14 87,61 -1,34% 2,03% 9.449.100